CoChat
Sign Up
Cited by 210Adrenal and Paraganglionic TumorsRenal cell carcinoma treatmentAdrenal Hormones and Disorders

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Role of reoperation in recurrence of adrenal cortical carcinoma: Results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma

Bellantone, Rocco, Ferrante, Angela, Boscherini, Mauro, Lombardi, Celestino P, Crucitti, Pierfilippo, Crucitti, Francesco, Favia, Gennaro, Borrelli, Domenico, Boffi, Lamberto, Capussotti, Luigi, Carbone, Giovanni, Casaccia, Mario, Cavallaro, Antonio, Del Gaudio, Antonio, Dettori, Giuseppe, Di Giovanni, Vincenzo, Mazziotti, Alighiero, Marrano, Domenico, Masenti, Ettore, Miccoli, Paolo, Mosca, Franco, Mussa, Antonio, Petronio, Renato, Piat, Gianpaolo, Ruberti, Ugo, Serio, Giuseppe, Marzano, Luigi·1997·Surgery
DOI 10.1016/s0039-6060(97)90229-4
Open this paper in CoChat — free account

Abstract

Background Recurrence of adrenal cortical carcinoma (ACC) after radical surgery is a common finding. Although successful reoperations have been reported with encouraging results, most published experiences are anecdotal and based on few cases. We report the results of surgical treatment for recurrent ACC in a multiinstitutional series.Methods One hundred eighty-eight cases of ACC were collected in a national registry. A complete follow-up was obtained in 179 cases. At initial diagnosis 92 patients had local disease (stage I or II). One hundred seventy patients underwent surgical treatment, considered radical in 140; in this group, recurrent disease was observed in 52 cases (37%) after a mean disease-free interval of 21.7 months.Results Adjuvant chemotherapy was ineffective in ameliorating the prognosis. The mean survival in 20 patients who underwent reoperation was significantly higher (15.85 +/- 14.9 months) than in nonreoperated cases (3.2 +/- 2.9 months). Five-year actuarial survival in reoperated patients is significantly better than in nonreoperated patients (49.7% versus 8.3%, respectively).Conclusions Although the prognosis of this tumor is still poor, surgery is the only effective therapy; reoperation allows survival comparable to that observed in patients without recurrent disease. An aggressive strategy for recurrent ACC is advisable until prospective studies demonstrate a real effectiveness for chemotherapy.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0039-6060(97)90229-4

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

Sorted by citations

See all 210

Related

Metadata

Authors
Bellantone, R., Ferrante, A., Boscherini, M., Lombardi, C. P., Crucitti, P., Crucitti, F., Favia, G., Borrelli, D., Boffi, L., Capussotti, L., Carbone, G., Casaccia, M., Cavallaro, A., Del Gaudio, A., Dettori, G., Di Giovanni, V., Mazziotti, A., Marrano, D., Masenti, E., Miccoli, P., Mosca, F., Mussa, A., Petronio, R., Piat, G., Ruberti, U., Serio, G., & Marzano, L.
Affiliations
Agostino Gemelli University Polyclinic (IT)
Corresponding author
Ferrante, Angela
ORCID
Venue
Surgery
Publisher
Elsevier BV
Published
1997-12
Volume
122
Issue
6
Pages
1212-1218
ISSN
0039-6060 (ISSN-L)
DOI
10.1016/s0039-6060(97)90229-4
OpenAlex
W2084654797
Cited by
210
References
28
Citations by year
2026: 2 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 8 · 2019: 9 · 2018: 11 · 2017: 10 · 2016: 9 · 2015: 13 · 2014: 17 · 2013: 8 · 2012: 13
FWCI
1.92
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Surgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
adrenocortical carcinoma, tumor recurrence, reoperation, adjuvant chemotherapy, survival, prognosis, disease-free interval
MeSH terms
Adolescent, Adrenal Cortex Neoplasms, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Reoperation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review